OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Edgardo D. Carosella, Benoı̂t Favier, Nathalie Rouas‐Freiss, et al.
Blood (2008) Vol. 111, Iss. 10, pp. 4862-4870
Open Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Maria Ester Bernardo, Willem E. Fibbe
Cell stem cell (2013) Vol. 13, Iss. 4, pp. 392-402
Open Access | Times Cited: 1247

The Role of the Immune System in Autism Spectrum Disorder
Amory Meltzer, Judy Van de Water
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 284-298
Open Access | Times Cited: 451

Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications
Marta Elena Castro-Manrreza, Juan José Montesinos
Journal of Immunology Research (2015) Vol. 2015, pp. 1-20
Open Access | Times Cited: 367

Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association
Eduardo Antônio Donadi, Erick C. Castelli, Antonio Arnaiz‐Villena, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 369-395
Open Access | Times Cited: 352

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, et al.
Journal of Thoracic Oncology (2010) Vol. 6, Iss. 4, pp. 824-833
Open Access | Times Cited: 312

Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Carla Riera‐Domingo, Annette Audigé, Sara Granja, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 1-102
Open Access | Times Cited: 251

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella, Guillaume Ploussard, Joël LeMaoult, et al.
European Urology (2015) Vol. 68, Iss. 2, pp. 267-279
Closed Access | Times Cited: 213

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
Yiliang Li, Sapna P. Patel, Jason Roszik, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 174

The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes
Erick C. Castelli, Celso Teixeira Mendes‐Junior, Neifi Hassan Saloum Deghaide, et al.
Genes and Immunity (2009) Vol. 11, Iss. 2, pp. 134-141
Closed Access | Times Cited: 209

The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190

KIR2DL4 (CD158d): An activation receptor for HLA-G
Sumati Rajagopalan, Eric O. Long
Frontiers in Immunology (2012) Vol. 3
Open Access | Times Cited: 171

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
Peimin Chen, Ming‐Shyen Yen, Ko‐Jiunn Liu, et al.
Journal of Biomedical Science (2011) Vol. 18, Iss. 1
Open Access | Times Cited: 171

In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes
Erick C. Castelli, Philippe Moreau, Alynne Oya e Chiromatzo, et al.
Human Immunology (2009) Vol. 70, Iss. 12, pp. 1020-1025
Closed Access | Times Cited: 165

The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur, Simon Jasinski, Barbara Seliger
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 350-358
Closed Access | Times Cited: 160

A Comprehensive Study of Polymorphic Sites along the HLA-G Gene: Implication for Gene Regulation and Evolution
Erick C. Castelli, Celso Teixeira Mendes‐Junior, Luciana C. Veiga‐Castelli, et al.
Molecular Biology and Evolution (2011) Vol. 28, Iss. 11, pp. 3069-3086
Open Access | Times Cited: 157

Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl4-Treated Mice
Ursula Manuelpillai, Jorge Tchongue, Dinushka Lourensz, et al.
Cell Transplantation (2010) Vol. 19, Iss. 9, pp. 1157-1168
Open Access | Times Cited: 150

Role of non-classical MHC class I molecules in cancer immunosuppression
Grazyna Kochan, David Escors, Karine Breckpot, et al.
OncoImmunology (2013) Vol. 2, Iss. 11, pp. e26491-e26491
Open Access | Times Cited: 146

Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects
Magali J. Fontaine, Hank Shih, Richard Schäfer, et al.
Transfusion Medicine Reviews (2015) Vol. 30, Iss. 1, pp. 37-43
Closed Access | Times Cited: 146

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugué, Edgardo D. Carosella, Nathalie Rouas‐Freiss
Blood (2011) Vol. 117, Iss. 26, pp. 7021-7031
Closed Access | Times Cited: 132

Tumor Microenvironment: A New Treatment Target for Cancer
Ming‐Ju Tsai, Wei‐An Chang, Ming‐Shyan Huang, et al.
ISRN Biochemistry (2014) Vol. 2014, pp. 1-8
Open Access | Times Cited: 130

Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120

Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120

HLA-G Molecules in Autoimmune Diseases and Infections
Roberta Rizzo, Daria Bortolotti, Silvia Bolzani, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 111

Page 1 - Next Page

Scroll to top